T46.0X Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action

Name of the Condition

• Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action

Summary

This condition encompasses three scenarios related to cardiac-stimulant glycosides and similar drugs: poisoning (overdose), adverse effects from therapeutic use, and underdosing (insufficient intake). Cardiac-stimulant glycosides, such as digoxin, are used to treat heart conditions like atrial fibrillation and heart failure. The diagnosis depends on the clinical context, whether the issue stems from excessive intake, unintended reactions, or inadequate dosing.

Causes

Poisoning may result from accidental or intentional overdose of cardiac-stimulant glycosides. Adverse effects occur when the body reacts negatively to these drugs at therapeutic doses, often due to individual sensitivity or drug interactions. Underdosing happens when a patient takes less than the prescribed amount, which can be intentional (e.g., due to side effects) or unintentional (e.g., missed doses).

Risk Factors

• Advanced age, as metabolism and kidney function may alter drug processing.
• Kidney disease, which reduces clearance of glycosides and increases toxicity risk.
• Concurrent use of medications that interact with cardiac glycosides (e.g., certain diuretics or antibiotics).
• History of heart failure or arrhythmias, where these drugs are commonly prescribed.
• Poor medication adherence or misunderstanding of dosing instructions.

Symptoms

• Nausea, vomiting, or loss of appetite.
• Visual disturbances (e.g., blurred vision, yellow-green halos around objects).
• Irregular heartbeat (arrhythmias), including bradycardia or tachycardia.
• Dizziness, confusion, or fatigue.
• In severe cases: seizures, coma, or cardiac arrest.

Diagnosis

Diagnosis involves a thorough patient history to determine the context (poisoning, adverse effect, or underdosing). Physical examination focuses on cardiac and neurological signs. Laboratory tests include measuring serum drug levels (e.g., digoxin levels), electrolytes (especially potassium), and kidney function. Electrocardiogram (ECG) may reveal arrhythmias or conduction abnormalities.

Treatment Options

• For poisoning: Activated charcoal (if recent ingestion), antidotes (e.g., digoxin-specific Fab fragments), and supportive care (e.g., monitoring, electrolyte correction).
• For adverse effects: Discontinuing the drug, adjusting dosage, or switching to an alternative medication.
• For underdosing: Re-educating the patient on adherence, simplifying the regimen, or addressing barriers (e.g., cost, side effects).

Prognosis and Follow-Up

Prognosis varies by severity and timely intervention. Mild cases may resolve with dose adjustments, while severe poisoning can be life-threatening. Follow-up includes monitoring drug levels, cardiac function, and electrolytes. Long-term management focuses on preventing recurrence through patient education and regular check-ins.

Complications

• Severe arrhythmias (e.g., ventricular tachycardia) leading to cardiac arrest.
• Kidney injury from toxicity or dehydration.
• Neurological damage from prolonged low oxygen or drug effects.
• Worsening heart failure if underdosing is unaddressed.

Lifestyle & Prevention

• Take medications exactly as prescribed; use pill organizers or reminders for adherence.
• Avoid alcohol and over-the-counter drugs that may interact with cardiac glycosides.
• Maintain regular follow-ups to monitor drug levels and kidney function.
• Report side effects (e.g., nausea, visual changes) to a healthcare provider promptly.

When to Seek Professional Help

Seek immediate care for symptoms like severe dizziness, fainting, irregular heartbeat, or confusion. Contact a provider if you miss doses frequently or experience persistent side effects. Emergency services are critical for suspected overdose or sudden cardiac symptoms.

Tips for Medical Coders

Document the clinical context clearly (poisoning, adverse effect, or underdosing) to assign the correct code. Specify whether the encounter is initial, subsequent, or sequela. Include details on drug levels, symptoms, and treatment to support coding accuracy. Note that this code covers a broad category, so ensure documentation aligns with the specific scenario (e.g., "adverse effect" vs. "poisoning").